Rituximab (MabThera / Rituxan)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Rituximab (MabThera / Rituxan), covering 2014-09-10 to 2016-08-17. Get the full timeline:
Most recent: Clinical Trial Update: An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent